0001493152-21-018911.txt : 20210806 0001493152-21-018911.hdr.sgml : 20210806 20210806170042 ACCESSION NUMBER: 0001493152-21-018911 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210804 FILED AS OF DATE: 20210806 DATE AS OF CHANGE: 20210806 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Linscott Walt Addison CENTRAL INDEX KEY: 0001648585 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40652 FILM NUMBER: 211153642 MAIL ADDRESS: STREET 1: 1860 MONTREAL ROAD CITY: TUCKER STATE: GA ZIP: 30084 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Indaptus Therapeutics, Inc. CENTRAL INDEX KEY: 0001857044 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 863158720 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 347-480-9760 MAIL ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: Intec Parent Inc. DATE OF NAME CHANGE: 20210414 4 1 ownership.xml X0306 4 2021-08-04 0 0001857044 Indaptus Therapeutics, Inc. INDP 0001648585 Linscott Walt Addison C/O INDAPTUS THERAPEUTICS, INC. 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY 10019 0 1 0 0 Chief Business Officer Stock Option (right to buy) 8.87 2021-08-04 4 A 0 210000 0 A 2031-08-04 Common Stock 210000 210000 D The stock option vests and becomes exercisable as to one-third of the total shares on August 4, 2022 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months. /s/ Walt Linscott 2021-08-06